The review found that semaglutide and tirzepatide showed the highest reported rates of hair loss signals among GLP-1 therapies , with telogen effluvium and androgenetic alopecia being the most commonly reported hair-loss patterns
The peptides are gone, but the hormonal cascade they triggered is still resolving
When to Seek Immediate Care Contact your provider or go to the emergency room if you experience: Severe abdominal pain or a rigid, board-like abdomen High fever (above 101F / 38.3C) with abdominal pain Significant rectal bleeding or blood in stool Signs of bowel obstruction: severe cramping, vomiting, inability to pass gas or stool Sudden worsening of symptoms in a patient on biologic therapy (may indicate infection) About this Guide This Clinical Documentation Guide is published by CCO Academy and is intended for credentialed coding, CDI, and clinical documentation professionals
For a regulator-level summary of common and serious glp-1 side effects, review the FDAs prescribing information for semaglutide, which outlines class warnings, adverse reactions, and use recommendations
.webp)
